Jiangsu Bioperfectus Technologies Co., Ltd. (688399.SS)
CNY 68.99
(-0.95%)
CNY 68.99
(-0.95%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -1.59 Billion CNY | 5.48% |
| 2022 | -1.68 Billion CNY | -50.31% |
| 2021 | -1.12 Billion CNY | -3.17% |
| 2020 | -1.08 Billion CNY | -338.09% |
| 2019 | -248.51 Million CNY | -17.18% |
| 2018 | -212.07 Million CNY | -883.06% |
| 2017 | -21.57 Million CNY | -76.56% |
| 2016 | -12.21 Million CNY | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q1 | -1.96 Billion CNY | -23.42% |
| 2024 Q3 | -891.32 Million CNY | 32.21% |
| 2024 Q2 | -1.3 Billion CNY | 33.91% |
| 2023 Q4 | -1.59 Billion CNY | -17.52% |
| 2023 FY | -1.59 Billion CNY | 5.48% |
| 2023 Q3 | -1.35 Billion CNY | 30.76% |
| 2023 Q2 | -1.96 Billion CNY | 5.87% |
| 2023 Q1 | -2.08 Billion CNY | -23.4% |
| 2022 Q4 | -1.68 Billion CNY | -10.94% |
| 2022 Q3 | -1.52 Billion CNY | -7.32% |
| 2022 Q2 | -1.41 Billion CNY | 5.84% |
| 2022 Q1 | -1.5 Billion CNY | -34.08% |
| 2022 FY | -1.68 Billion CNY | -50.31% |
| 2021 FY | -1.12 Billion CNY | -3.17% |
| 2021 Q2 | -713.88 Million CNY | 27.67% |
| 2021 Q1 | -986.92 Million CNY | 9.35% |
| 2021 Q3 | -914.77 Million CNY | -28.14% |
| 2021 Q4 | -1.12 Billion CNY | -22.79% |
| 2020 Q3 | -524.32 Million CNY | -38.77% |
| 2020 Q1 | -184.77 Million CNY | 25.7% |
| 2020 FY | -1.08 Billion CNY | -338.09% |
| 2020 Q4 | -1.08 Billion CNY | -107.64% |
| 2020 Q2 | -377.82 Million CNY | -104.47% |
| 2019 Q3 | -179.35 Million CNY | 9.69% |
| 2019 Q2 | -198.6 Million CNY | -193.62% |
| 2019 Q1 | 212.13 Million CNY | 200.03% |
| 2019 Q4 | -248.69 Million CNY | -38.66% |
| 2019 FY | -248.51 Million CNY | -17.18% |
| 2018 Q4 | -212.07 Million CNY | 0.0% |
| 2018 FY | -212.07 Million CNY | -883.06% |
| 2017 FY | -21.57 Million CNY | -76.56% |
| 2016 FY | -12.21 Million CNY | 0.0% |